- Home
- REPX vs VOR Comparison
REPX vs VOR Comparison
Compare REPX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REPX | VOR |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 963.9M | 1.1B |
| IPO Year | 2003 | 2021 |
Fundamental Metrics
Financial Performance| Metric | REPX | VOR |
|---|---|---|
| Price | $45.48 | $19.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $46.00 | $39.00 |
| AVG Volume (30 Days) | 252.7K | ★ 1.2M |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | ★ 78.17 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $3,038,000.00 | N/A |
| Revenue This Year | $52.25 | N/A |
| Revenue Next Year | $6.87 | N/A |
| P/E Ratio | $55.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.08 | $6.50 |
| 52 Week High | $45.31 | $33.42 |
Technical Indicators
Market Signals| Indicator | REPX | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 69.75 | 47.19 |
| Support Level | $32.27 | $17.10 |
| Resistance Level | N/A | $24.23 |
| Average True Range (ATR) | 1.28 | 1.37 |
| MACD | 0.25 | 0.06 |
| Stochastic Oscillator | 94.00 | 35.87 |
Price Performance
Historical ComparisonAbout REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations include: The Permian Basin is an oil and natural gas producing area located in West Texas.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.